-
Alternative_name
2-[1-[4-[2-(4-Chlorophenoxy)acetyl]-1-piperazinyl]ethyl]-3-(2-ethoxyphenyl)-4(3H)-Quinazolinone
-
Description
Erastin is a selective antitumor agent that displays greater lethality in human tumour cells harbouring mutations in the oncogenes HRAS, KRAS or BRAF. It binds to mitochondrial volatage-dependent anion channels (VDAC) proteins, more specifically on VDAC2 and alters its gating. Erastin rapidly induces an oxidative, non-apoptotic cell death in several human tumors harboring activating mutations in the RAS-RAF-MEK signaling.
-
CAS Number
571203-78-6
-
Structure Available
Yes
-
Salt Form
No
-
Molecular Formula
C₃₀H₃₁ClN₄O₄
-
Molecular Weight
547.04
-
Cell Permeable
Yes
-
Purity
≥98% by HPLC
-
Solubilities
DMSO (>50 mg/ml)
-
Handling
Protect from light and moisture
-
Tag Line
An antitumor agent with RAS-selective lethality.
-
Storage Condition
-20°C
-
Shipping Condition
gel pack
-
Shelf Life
24 months
-
MDL Number
MFCD09837984
-
PubChem CID
11214940
-
-
SMILES
CCOC1=CC=CC=C1N2C(=O)C3=CC=CC=C3N=C2C(C)N4CCN(CC4)C(=O)COC5=CC=C(C=C5)Cl
-
InChi
InChI=1S/C30H31ClN4O4/c1-3-38-27-11-7-6-10-26(27)35-29(32-25-9-5-4-8-24(25)30(35)37)21(2)33-16-18-34(19-17-33)28(36)20-39-23-14-12-22(31)13-15-23/h4-15,21H,3,16-20H2,1-2H3
-
InChi Key
BKQFRNYHFIQEKN-UHFFFAOYSA-N
-
-
MSDS Available
Yes